Five Prime Thera (FPRX) Stock Price, Quote, News and Overview
NASDAQ:FPRX - Nasdaq -
FPRX Quote, Performance and Key Statistics
38
+0.01 (+0.03%)
The current stock price of FPRX is 38 null. In the past month the price increased by 0.32%. In the past year, price increased by 1257.14%.
About FPRX
Company Profile
Five Prime Therapeutics, Inc. is a biotechnology company. The company focuses on the discovery and development of protein therapeutics that blocks cancer and inflammatory disease processes. It operates primarily in the United States and Canada. Five Prime Therapeutics, Inc. is based in San Francisco, California.
Company Info
Five Prime Thera
111 Oyster Point Boulevard
South San Francisco CA 94080
CEO: Thomas Civik
Phone: 415-365-5600
Five Prime Thera / FPRX FAQ
What is the stock price of Five Prime Thera today?
The current stock price of FPRX is 38 null. The price increased by 0.03% in the last trading session.
What is the ticker symbol for Five Prime Thera stock?
The exchange symbol of Five Prime Thera is FPRX and it is listed on the Nasdaq exchange.
On which exchange is FPRX stock listed?
FPRX stock is listed on the Nasdaq exchange.
What is Five Prime Thera worth?
Five Prime Thera (FPRX) has a market capitalization of 1.77B null. This makes FPRX a Small Cap stock.
What are the support and resistance levels for Five Prime Thera (FPRX) stock?
Five Prime Thera (FPRX) has a support level at 37.91 and a resistance level at 38. Check the full technical report for a detailed analysis of FPRX support and resistance levels.
Should I buy Five Prime Thera (FPRX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FPRX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FPRX, evaluating the profitability, health, valuation and growth aspects
- Five Prime Thera (FPRX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Five Prime Thera (FPRX) Sales and EPS estimates to see what analysts future expectations are.
- Five Prime Thera (FPRX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Five Prime Thera (FPRX) Insider and Institutional Ownership to learn about the owners and their transactions.
- Five Prime Thera (FPRX) Stock Chart to make your own analysis
- Five Prime Thera (FPRX) Latest news and press-releases to stay up to date.
Does Five Prime Thera (FPRX) stock pay dividends?
FPRX does not pay a dividend.
What is the Price/Earnings (PE) ratio of Five Prime Thera (FPRX)?
Five Prime Thera (FPRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.29).
FPRX Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to FPRX. When comparing the yearly performance of all stocks, FPRX is one of the better performing stocks in the market, outperforming 99.32% of all stocks.
FPRX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to FPRX. No worries on liquidiy or solvency for FPRX as it has an excellent financial health rating, but there are worries on the profitability.
FPRX Financial Highlights
Over the last trailing twelve months FPRX reported a non-GAAP Earnings per Share(EPS) of -2.29. The EPS increased by 41.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -639.92% | ||
| ROA | -25.43% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
FPRX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 75% to FPRX. The Buy consensus is the average rating of analysts ratings from 8 analysts.